First Time Loading...

Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 71.45 CHF 0.21% Market Closed
Updated: May 15, 2024

Intrinsic Value

Galenica AG engages as a health care provider in Switzerland. [ Read More ]

The intrinsic value of one GALE stock under the Base Case scenario is 92.53 CHF. Compared to the current market price of 71.45 CHF, Galenica AG is Undervalued by 23%.

Key Points:
GALE Intrinsic Value
Base Case
92.53 CHF
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Galenica AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GALE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Galenica AG

Provide an overview of the primary business activities
of Galenica AG.

What unique competitive advantages
does Galenica AG hold over its rivals?

What risks and challenges
does Galenica AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Galenica AG.

Provide P/S
for Galenica AG.

Provide P/E
for Galenica AG.

Provide P/OCF
for Galenica AG.

Provide P/FCFE
for Galenica AG.

Provide P/B
for Galenica AG.

Provide EV/S
for Galenica AG.

Provide EV/GP
for Galenica AG.

Provide EV/EBITDA
for Galenica AG.

Provide EV/EBIT
for Galenica AG.

Provide EV/OCF
for Galenica AG.

Provide EV/FCFF
for Galenica AG.

Provide EV/IC
for Galenica AG.

Show me price targets
for Galenica AG made by professional analysts.

What are the Revenue projections
for Galenica AG?

How accurate were the past Revenue estimates
for Galenica AG?

What are the Net Income projections
for Galenica AG?

How accurate were the past Net Income estimates
for Galenica AG?

What are the EPS projections
for Galenica AG?

How accurate were the past EPS estimates
for Galenica AG?

What are the EBIT projections
for Galenica AG?

How accurate were the past EBIT estimates
for Galenica AG?

Compare the revenue forecasts
for Galenica AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Galenica AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Galenica AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Galenica AG compared to its peers.

Compare the P/E ratios
of Galenica AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Galenica AG with its peers.

Analyze the financial leverage
of Galenica AG compared to its main competitors.

Show all profitability ratios
for Galenica AG.

Provide ROE
for Galenica AG.

Provide ROA
for Galenica AG.

Provide ROIC
for Galenica AG.

Provide ROCE
for Galenica AG.

Provide Gross Margin
for Galenica AG.

Provide Operating Margin
for Galenica AG.

Provide Net Margin
for Galenica AG.

Provide FCF Margin
for Galenica AG.

Show all solvency ratios
for Galenica AG.

Provide D/E Ratio
for Galenica AG.

Provide D/A Ratio
for Galenica AG.

Provide Interest Coverage Ratio
for Galenica AG.

Provide Altman Z-Score Ratio
for Galenica AG.

Provide Quick Ratio
for Galenica AG.

Provide Current Ratio
for Galenica AG.

Provide Cash Ratio
for Galenica AG.

What is the historical Revenue growth
over the last 5 years for Galenica AG?

What is the historical Net Income growth
over the last 5 years for Galenica AG?

What is the current Free Cash Flow
of Galenica AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Galenica AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Galenica AG

Current Assets 1B
Cash & Short-Term Investments 116.2m
Receivables 518.3m
Other Current Assets 399.1m
Non-Current Assets 2B
Long-Term Investments 364.2m
PP&E 489.3m
Intangibles 1.1B
Other Non-Current Assets 25.4m
Current Liabilities 772.3m
Accounts Payable 417.4m
Accrued Liabilities 195.6m
Other Current Liabilities 159.2m
Non-Current Liabilities 747.3m
Long-Term Debt 654.1m
Other Non-Current Liabilities 93.1m
Efficiency

Earnings Waterfall
Galenica AG

Revenue
3.7B CHF
Cost of Revenue
-2.7B CHF
Gross Profit
1B CHF
Operating Expenses
-850m CHF
Operating Income
191.6m CHF
Other Expenses
93.7m CHF
Net Income
285.4m CHF

Free Cash Flow Analysis
Galenica AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

GALE Profitability Score
Profitability Due Diligence

Galenica AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive ROE
52/100
Profitability
Score

Galenica AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

GALE Solvency Score
Solvency Due Diligence

Galenica AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
68/100
Solvency
Score

Galenica AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GALE Price Targets Summary
Galenica AG

Wall Street analysts forecast GALE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GALE is 78.03 CHF with a low forecast of 71.71 CHF and a high forecast of 85.05 CHF.

Lowest
Price Target
71.71 CHF
0% Upside
Average
Price Target
78.03 CHF
9% Upside
Highest
Price Target
85.05 CHF
19% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GALE Price
Galenica AG

1M 1M
+1%
6M 6M
+2%
1Y 1Y
-6%
3Y 3Y
+16%
5Y 5Y
+56%
10Y 10Y
+92%
Annual Price Range
71.45
52w Low
65.45
52w High
78
Price Metrics
Average Annual Return 13.62%
Standard Deviation of Annual Returns 10.47%
Max Drawdown -19%
Shares Statistics
Market Capitalization 3.6B CHF
Shares Outstanding 49 816 260
Percentage of Shares Shorted
N/A

GALE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Galenica AG Logo
Galenica AG

Country

Switzerland

Industry

Health Care

Market Cap

3.6B CHF

Dividend Yield

3.09%

Description

Galenica AG engages as a health care provider in Switzerland. The company is headquartered in Bern, Bern and currently employs 5,533 full-time employees. The company went IPO on 2017-04-07. The firm's business i divided into three business sectors: Retail, Products & Brands, and Services. The firm manages a locally established pharmacies network in Switzerland. The company develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Contact

BERN
Bern
Untermattweg 8
+41588528111.0
https://www.galenica.com/

IPO

2017-04-07

Employees

5 533

Officers

Chief Executive Officer
Mr. Marc Werner
CFO & Head of Investor Relations
Mr. Felix Burkhard
General Counsel & Secretary of the Board of Directors
Ms. Barbara Walchli
Head of Corporate Communications
Mr. Iris Muller
Chief Products & Marketing Officer
Dr. Thomas F. Szuran
Chief People & Culture
Ms. Arianne Hasler
Show More
Advisor
Dr. Jörg Kneubühler
Chief Healthcare Officer
Mr. Daniele Madonna
Head of Wholesale & Logistics
Mr. Andreas Koch
Chief Pharmacies Officer
Ms. Virginie Pache Jeschka
Show Less

See Also

Discover More
What is the Intrinsic Value of one GALE stock?

The intrinsic value of one GALE stock under the Base Case scenario is 92.53 CHF.

Is GALE stock undervalued or overvalued?

Compared to the current market price of 71.45 CHF, Galenica AG is Undervalued by 23%.